Advisor Group’s Chembio diagnostics, Inc. CEMI Stock Holding History

Advisor Group’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$4K	Buy	900 +450	+100%	+$2.19K	﹤0.01%	4814
2019 Q3	$3K	Hold	450	–	–	﹤0.01%	4929
2019 Q2	$3K	Sell	450 -450	-50%	-$3.04K	﹤0.01%	4935
2019 Q1	$5K	Hold	900	–	–	﹤0.01%	4739
2018 Q4	$5K	Hold	900	–	–	﹤0.01%	4572
2018 Q3	$9K	Hold	900	–	–	﹤0.01%	4366
2018 Q2	$10K	Hold	900	–	–	﹤0.01%	4102
2018 Q1	$7K	Hold	900	–	–	﹤0.01%	4306
2017 Q4	$7K	Hold	900	–	–	﹤0.01%	4312
2017 Q3	$6K	Hold	900	–	–	﹤0.01%	4247
2017 Q2	$5K	Hold	900	–	–	﹤0.01%	4289
2017 Q1	$5K	Hold	900	–	–	﹤0.01%	4165
2016 Q4	$6K	Hold	900	–	–	﹤0.01%	3901
2016 Q3	$7K	Sell	900 -1,600	-64%	-$11.5K	﹤0.01%	3789
2016 Q2	$20K	Buy	+2,500	New	+$19.5K	﹤0.01%	3081

Other funds holding CEMI

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Advisor Group's CEMI Position: Q4 2019 in Review

Advisor Group increased its Chembio diagnostics, Inc. (CEMI) stake by 100% in Q4 2019, buying an estimated $2.19K and bringing the position to 900 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4814.

Advisor Group first reported a position in CEMI in Q2 2016 and has held it in 15 quarters since. The position peaked at $20K in Q2 2016. 39 funds tracked by Wall St. Rank hold CEMI as of Q4 2019.

Advisor Group held 900 shares of Chembio diagnostics, Inc. worth $4K as of Q4 2019.
Advisor Group bought 450 Chembio diagnostics, Inc. shares in Q4 2019, an estimated $2.19K.
Chembio diagnostics, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4814 holding.
Advisor Group first reported a position in Chembio diagnostics, Inc. in Q2 2016 and has held it in 15 quarters since.
Advisor Group's Chembio diagnostics, Inc. position peaked at $20K in Q2 2016.
39 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.